Polymorphisms in TGFBR3 have been previously associated with clinical manifestations in SCD, such as pain crisis, ACS, infection, stroke, leg ulcers, priapism, osteonecrosis, and PH [7, 9–15]. This evidence concerns the gene TGFBR3 and Priapism.